Manas AI
Last verified 2026-05-05. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $24.6Mattributed |
|---|---|
| Latest round | seed, $24.6M, 2025-01-27attributed |
| Founded | 2024 |
| Headquarters | San Francisco, USA |
| Industry | healthtech |
| Stage | seed |
| Website | manasai.co |
Manas AI builds an AI platform that accelerates pharmaceutical drug discovery from target identification through clinical trials. It serves biopharma companies and research organizations aiming to cut the time and cost of new medicines. Its neuro-symbolic AI codifies first-principles rules from chemistry, physics, and biology.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-01-27 | seed | $24.6M | greylock |
Detected tech stack
Vercel, Next.js, React, Webpack
Provenance
| Fact | Status | Basis |
|---|---|---|
| Seed, $24.6M | attributed | news-misc named as publisher. No document URL on file. |
| Total raised $24.6M | attributed | news-misc named as publisher. No document URL on file. |
| Company existence | self-reported | manasai.co, read 2026-05-05 |
| Description | self-reported | manasai.co, read 2026-05-05 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.